• Explore /
  • Poster
  • / Registrational dataset from the phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET fusion+ non-small cell lung cancer (NSCLC).

Registrational dataset from the phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET fusion+ non-small cell lung cancer (NSCLC).

Abstract Video & Slides Poster

Authors

null

Justin F. Gainor

Massachusetts General Hospital, Boston, MA

Justin F. Gainor , Giuseppe Curigliano , Dong-Wan Kim , Dae Ho Lee , Benjamin Besse , Christina S Baik , Robert C Doebele , Philippe Alexandre Cassier , Gilberto Lopes , Daniel Shao-Weng Tan , Elena Garralda , Luis G. Paz-Ares , Byoung Chul Cho , Shirish M. Gadgeel , Michael Thomas , Stephen V. Liu , Corinne Clifford , Hui Zhang , Christopher D. Turner , Vivek Subbiah

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT03037385

Citation

J Clin Oncol 38: 2020 (suppl; abstr 9515)

DOI

10.1200/JCO.2020.38.15_suppl.9515

Abstract #

9515

Poster Bd #

281

Abstract Disclosures

Similar Posters

First Author: Vivek Subbiah

First Author: Giuseppe Curigliano

First Author: Caicun Zhou

First Author: Sanjay Popat